Meridian Wealth Management, LLC Crispr Therapeutics Ag Transaction History

Meridian Wealth Management, LLC

  • $2.07 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 22, 2021
SELL
$100.84 - $161.89 $201,680 - $323,780
-2,000 Closed
0 $0
Q1 2021

May 07, 2021
BUY
$110.72 - $210.04 $24,026 - $45,578
217 Added 12.17%
2,000 $244,000
Q4 2020

Jan 19, 2021
BUY
$79.67 - $173.23 $142,051 - $308,869
1,783 New
1,783 $272,000

Others Institutions Holding CRSP

# of Institutions
494
Shares Held
64.3M
Call Options Held
1.68M
Put Options Held
1.95M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.88B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Meridian Wealth Management, LLC Portfolio

Follow Meridian Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meridian Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Meridian Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email